CN105012733A - Traditional Chinese medicine composition for treating erythroderma - Google Patents
Traditional Chinese medicine composition for treating erythroderma Download PDFInfo
- Publication number
- CN105012733A CN105012733A CN201510430703.2A CN201510430703A CN105012733A CN 105012733 A CN105012733 A CN 105012733A CN 201510430703 A CN201510430703 A CN 201510430703A CN 105012733 A CN105012733 A CN 105012733A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- traditional chinese
- medicine composition
- erythroderma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine composition for treating erythroderma. The traditional Chinese medicine composition for treating the erythroderma is prepared from, by weight, 4-8 parts of prunella vulgaris, 8-14 parts of dried radix rehmanniae, 15-20 parts of radix scrophulariae, 5-10 parts of borneol, 6-10 parts of couchgrass roots, 10-17 parts of arctium lappa, 12-18 parts of rhizoma anemarrhenae and 7-14 parts of herba schizonepetae. The traditional Chinese medicine composition for treating the erythroderma has the advantages that based on the modern science and biological technologies, the traditional Chinese medicine composition is obtained by means of scientifically proportioning raw materials and subjecting the traditional Chinese medicines to supercritical carbon dioxide extraction; when the traditional Chinese medicine composition is compared with traditional Chinese medicine compositions decocted with water in the prior art, various effective components are extracted more easily under pressurization, utilization ratio of the traditional Chinese medicines is high, sterilizing and antibacterial effects are better, safety is high, and the traditional Chinese medicine composition has special traditional Chinese medicine fragrance and assures patients when used; the traditional Chinese medicine composition is scientific in formula, simple to prepare, capable of treating both symptoms and root causes and treating the erythroderma effectively, notable in curative effect, high in cure rate, safe and free of toxic and side effects.
Description
Technical field
The present invention relates to field of medicaments, be specifically related to a kind of Chinese medicine composition for the treatment of erythroderma.
Background technology
Erythroderma is also known as exfoliative dermatitis, be a kind of involve whole body with diffusivity flushing, the a large amount of desquamation of persistence is main serious symptom chronic inflammatory skin disease, the traditional Chinese medical science thinks that this is that heart-fire is flourishing, diseases caused by exogenous pathogenic factor poison is evil, scorchingly hot enter blood battalion, and cause intense heat in both QI and blood systems, burn body fluid, failure of skin and muscle to be nourished and causing, or eat taboo, poison heresy enters the visceral muscles natural fibre line of meat and falls ill, its early symptom is variant with cause of disease difference, medicine causer, there is history of clearly taking medicine, onset is hurried, be secondary to other skin patient, can due to medication not in time or inappropriate medication, these dermatosiss are made to form erythroderma to whole body development, then malignant tumor is caused, have a strong impact on patient body health, therefore be subject to the head of a family and medical circles extensively pay attention to, the traditional Chinese medical science is particular about conditioning, treating both the principal and secondary aspects of a disease, the effective agent of erythroderma is studied based on Chinese medicine, significant to raising patient health level.
Summary of the invention
For solving the problem, the invention discloses a kind of Chinese medicine composition for the treatment of erythroderma, scientific formulation, preparation is simple, and treating both the principal and secondary aspects of a disease, effectively can treat erythroderma, and evident in efficacy, cure rate is high, and safe without toxic side effect.
For achieving the above object, technical scheme of the present invention is as follows:
Treat a Chinese medicine composition for erythroderma, it is characterized in that: be made up of the raw material of following weight portion: Spica Prunellae 4-8 part, soil 8-14 part, Radix Scrophulariae 15-20 part, Borneolum Syntheticum 5-10 part, Rhizoma Imperatae 6-10 part, Fructus Arctii 10-17 part, Rhizoma Anemarrhenae 12-18 part, Herba Schizonepetae 7-14 part.
As a modification of the present invention, be made up of the raw material of following weight portion: Spica Prunellae 6 parts, 10 parts, soil, Radix Scrophulariae 18 parts, Borneolum Syntheticum 8 parts, Rhizoma Imperatae 8 parts, Fructus Arctii 15 parts, the Rhizoma Anemarrhenae 15 parts, Herba Schizonepetae 11 parts.
A kind of preparation method for the treatment of the Chinese medicine composition of erythroderma of the present invention, that after Spica Prunellae proportionally, soil, Radix Scrophulariae, Borneolum Syntheticum, Rhizoma Imperatae, Fructus Arctii, the Rhizoma Anemarrhenae, Herba Schizonepetae are adopted the carbon dioxide abstraction of boundary over zero, concentration is the extract of 0.5-1.5g/ml.
The invention has the beneficial effects as follows:
A kind of Chinese medicine composition for the treatment of erythroderma of the present invention, adopt modern science and technology biotechnology, selected raw material is through scientific allocation, and Chinese medicine extraction mode is the carbon dioxide abstraction of boundary over zero, compared with soak by water of the prior art, various effective ingredient under an increased pressure, is more easily extracted, and the utilization rate of Chinese medicine is high, sterilization and antibacterial effect better, safety is high, and has a kind of special Chinese medicine fragrance, allows people relieved during use; Scientific formulation of the present invention, preparation is simple, and treating both the principal and secondary aspects of a disease, effectively can treat erythroderma, and evident in efficacy, cure rate is high, and safe without toxic side effect.
Detailed description of the invention
Below in conjunction with detailed description of the invention, illustrate the present invention further, following detailed description of the invention should be understood and be only not used in for illustration of the present invention and limit the scope of the invention.
Embodiment 1
Treat a Chinese medicine composition for erythroderma, be made up of the raw material of following weight portion: Spica Prunellae 4 parts, 14 parts, soil, Radix Scrophulariae 15 parts, Borneolum Syntheticum 10 parts, Rhizoma Imperatae 6 parts, Fructus Arctii 17 parts, the Rhizoma Anemarrhenae 12 parts, Herba Schizonepetae 14 parts.
A kind of preparation method for the treatment of the Chinese medicine composition of erythroderma described in the present embodiment, that after Spica Prunellae proportionally, soil, Radix Scrophulariae, Borneolum Syntheticum, Rhizoma Imperatae, Fructus Arctii, the Rhizoma Anemarrhenae, Herba Schizonepetae are adopted the carbon dioxide abstraction of boundary over zero, concentration is the extract of 1.5g/ml.
Every day uses for 1 time, within 13 days, recovers, no sequel and side effect.
Embodiment 2
Treat a Chinese medicine composition for erythroderma, be made up of the raw material of following weight portion: Spica Prunellae 6 parts, 10 parts, soil, Radix Scrophulariae 18 parts, Borneolum Syntheticum 8 parts, Rhizoma Imperatae 8 parts, Fructus Arctii 15 parts, the Rhizoma Anemarrhenae 15 parts, Herba Schizonepetae 11 parts.
A kind of preparation method for the treatment of the Chinese medicine composition of erythroderma described in the present embodiment is that after Spica Prunellae proportionally, soil, Radix Scrophulariae, Borneolum Syntheticum, Rhizoma Imperatae, Fructus Arctii, the Rhizoma Anemarrhenae, Herba Schizonepetae are adopted the carbon dioxide abstraction of boundary over zero, concentration is the extract of 1g/ml.
Every day uses for 1 time, within 12 days, recovers, no sequel and side effect.
Technological means disclosed in the present invention program is not limited only to the technological means disclosed in above-mentioned embodiment, also comprises the technical scheme be made up of above technical characteristic combination in any.
Claims (3)
1. treat a Chinese medicine composition for erythroderma, it is characterized in that: be made up of the raw material of following weight portion: Spica Prunellae 4-8 part, soil 8-14 part, Radix Scrophulariae 15-20 part, Borneolum Syntheticum 5-10 part, Rhizoma Imperatae 6-10 part, Fructus Arctii 10-17 part, Rhizoma Anemarrhenae 12-18 part, Herba Schizonepetae 7-14 part.
2. a kind of Chinese medicine composition for the treatment of erythroderma according to claim 1, is characterized in that: be made up of the raw material of following weight portion: Spica Prunellae 6 parts, 10 parts, soil, Radix Scrophulariae 18 parts, Borneolum Syntheticum 8 parts, Rhizoma Imperatae 8 parts, Fructus Arctii 15 parts, the Rhizoma Anemarrhenae 15 parts, Herba Schizonepetae 11 parts.
3. treat the preparation method of the Chinese medicine composition of erythroderma for one kind, it is characterized in that: be that after Spica Prunellae proportionally, soil, Radix Scrophulariae, Borneolum Syntheticum, Rhizoma Imperatae, Fructus Arctii, the Rhizoma Anemarrhenae, Herba Schizonepetae are adopted the carbon dioxide abstraction of boundary over zero, concentration is the extract of 0.5-1.5g/ml.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510430703.2A CN105012733A (en) | 2015-07-22 | 2015-07-22 | Traditional Chinese medicine composition for treating erythroderma |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510430703.2A CN105012733A (en) | 2015-07-22 | 2015-07-22 | Traditional Chinese medicine composition for treating erythroderma |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105012733A true CN105012733A (en) | 2015-11-04 |
Family
ID=54403273
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510430703.2A Pending CN105012733A (en) | 2015-07-22 | 2015-07-22 | Traditional Chinese medicine composition for treating erythroderma |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105012733A (en) |
-
2015
- 2015-07-22 CN CN201510430703.2A patent/CN105012733A/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103007216A (en) | Chinese medicinal composition for treating chronic diarrhea | |
| CN103223081B (en) | Grass oil for treating arthritis and traumatic injury | |
| CN102218132B (en) | Medicinal composition for treating nasal bleeding | |
| CN103816391A (en) | Traditional Chinese medicinal wine for treating osteomyelitis and preparation method thereof | |
| CN105012733A (en) | Traditional Chinese medicine composition for treating erythroderma | |
| CN102008666B (en) | Drug for treating lumbocrural pain | |
| CN105055966A (en) | Traditional Chinese medicine composition for treating puerperal disease | |
| CN105311460A (en) | Traditional Chinese medicine for treating vascular neuralgia headache | |
| CN104288664A (en) | Medicine curing hypochondriacal neurosis and preparation method for medicine | |
| CN103432565A (en) | Gynaecological antiphlogistic and analgesic pharmaceutical formulation | |
| CN104027685A (en) | Traditional Chinese medicine (TCM) for treating edema during menstruation induced by qi stagnation and blood stasis symptom | |
| CN103505669A (en) | Medicament for treating enterobiasis | |
| CN105031367A (en) | Traditional Chinese medicine preparation for treating exfoliative keratolysis | |
| CN105213865A (en) | A kind of Chinese medicine composition for the treatment of coronary heart disease | |
| CN104147564A (en) | Formula for suppressing pain by diminishing inflammation | |
| CN105106882A (en) | Traditional Chinese medicine composition for treating frostbite | |
| CN104857229A (en) | Traditional Chinese medicine composition for curing body odor or kakidrosis and preparation method thereof | |
| CN104274804A (en) | Traditional Chinese medicine for treating hiccup | |
| CN104225189A (en) | Traditional Chinese medicine for treating intermenstrual aphthous stomatitis due to stomach-heat fumigation syndrome | |
| CN105079340A (en) | Traditional Chinese medicine for treating coronary heart disease with syndromes of qi deficiency and blood stasis | |
| CN105012558A (en) | Decoction for treating chronic eczema | |
| CN104147138A (en) | Traditional Chinese medicine composition for preventing and treating livestock and poultry escherichia coli diseases | |
| CN103127349A (en) | Medicine for treating traumatic injury | |
| CN105012490A (en) | Medicament for treating tinea cruris | |
| CN107582800A (en) | Treat Chinese medicine preparation and the preparation of lumbar muscle strain |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20151104 |